Marta Bonada
Marta Bonada has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Annica Piccardi
Department of Neurosurgery, Fondazione IRCCS Istituto Neurologico C. Besta , Milan
2 shared publicationsFrancesco DiMeco
Department of Neurosurgery, Fondazione IRCCS Istituto Neurologico C. Besta , Milan
2 shared publications- Massimiliano Del Bene
Department of Neurosurgery, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
2 shared publications - Andrea Bianconi
Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genova, Genova, Italy
1 shared publication Antonio Melcarne
Division of Neurosurgery, "Città della Salute e della Scienza" University Hospital, Department of Neuroscience "Rita Levi Montalcini", University of Turin, 10124, Turin, Italy
1 shared publicationAntonio Silvani
Department of Neuro-oncology, Fondazione IRCCS Istituto Neurologico Carlo Besta , Milan
1 shared publication
Latest Publications
- Open Access
- 14 July 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 28 (11) , 2637-2649
Focused ultrasound-mediated blood-brain barrier opening reshapes plasma extracellular vesicle size distribution without elevating concentration in glioblastoma patients
Background: Focused ultrasound-mediated blood-brain barrier opening (FUS-BBBO) is hypothesized to enhance liquid biopsy by facilitating the release of tumor material into the circulation. This study aimed to evaluate the impact of MR-guided FUS-BBBO on plasma extracellular vesicle (EV) concentrations and size distributions, alongside cell-free DNA (cfDNA) profiles, to determine the clinical efficacy of this approach in glioblastoma (GB) patients. Methods: We performed 14 MR-guided FUS-BBBO procedures in patients with GB with blood sampling 1 h before and 1 h after sonication. Plasma EVs were isolated by size-exclusion chromatography and quantified by tunable resistive pulse sensing technology. cfDNA concentration and fragment profiles were assessed using fluorometric and electrophoretic methods. Results: EV concentration showed no consistent change after FUS-BBBO, with marked inter-patient and inter-procedure heterogeneity. In contrast, EV size displayed a reproducible diameter reduction of ∼8-10 nm, driven predominantly by contraction of the upper tail of the size distribution, indicating selective modulation of larger vesicle subpopulations. cfDNA concentrations and fragmentation showed a heterogeneous pattern, with occasional patient-specific increases. Exploratory analyses revealed no significant associations between biomarker changes and procedural parameters except for treated volume. Conclusions: Our findings challenge the assumption that clinical BBBO uniformly increases biomarker abundance. The consistent shift toward smaller EVs suggests a selective modulation rather than an increased release. While BBBO may enhance the detectability of analytes that poorly cross the BBB, this may not apply to EVs, which are able to traverse the BBB under physiological conditions, further supporting their value as liquid-biopsy substrates in neuro-oncology. Future studies integrating clinical data with mechanistic models are necessary to refine FUS-enhanced diagnostic strategies.
- 14 July 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 28 (11) , 2637-2649
Open AccessFocused ultrasound-mediated blood-brain barrier opening reshapes plasma extracellular vesicle size distribution without elevating concentration in glioblastoma patients
Background: Focused ultrasound-mediated blood-brain barrier opening (FUS-BBBO) is hypothesized to enhance liquid biopsy by facilitating the release of tumor material into the circulation. This study aimed to evaluate the impact of MR-guided FUS-BBBO on plasma extracellular vesicle (EV) concentrations and size distributions, alongside cell-free DNA (cfDNA) profiles, to determine the clinical efficacy of this approach in glioblastoma (GB) patients. Methods: We performed 14 MR-guided FUS-BBBO procedures in patients with GB with blood sampling 1 h before and 1 h after sonication. Plasma EVs were isolated by size-exclusion chromatography and quantified by tunable resistive pulse sensing technology. cfDNA concentration and fragment profiles were assessed using fluorometric and electrophoretic methods. Results: EV concentration showed no consistent change after FUS-BBBO, with marked inter-patient and inter-procedure heterogeneity. In contrast, EV size displayed a reproducible diameter reduction of ∼8-10 nm, driven predominantly by contraction of the upper tail of the size distribution, indicating selective modulation of larger vesicle subpopulations. cfDNA concentrations and fragmentation showed a heterogeneous pattern, with occasional patient-specific increases. Exploratory analyses revealed no significant associations between biomarker changes and procedural parameters except for treated volume. Conclusions: Our findings challenge the assumption that clinical BBBO uniformly increases biomarker abundance. The consistent shift toward smaller EVs suggests a selective modulation rather than an increased release. While BBBO may enhance the detectability of analytes that poorly cross the BBB, this may not apply to EVs, which are able to traverse the BBB under physiological conditions, further supporting their value as liquid-biopsy substrates in neuro-oncology. Future studies integrating clinical data with mechanistic models are necessary to refine FUS-enhanced diagnostic strategies.
- Open Access
- 9 May 2025
- Published by Elsevier in Brain and Spine
- Vol. 5, 104277
Double fluorescence-guided surgery with 5-ALA and fluorescein sodium in grade 2 and grade 3 adult-type diffuse gliomas: retrospective analysis of 112 cases
- 9 May 2025
- Published by Elsevier in Brain and Spine
- Vol. 5, 104277
Open AccessDouble fluorescence-guided surgery with 5-ALA and fluorescein sodium in grade 2 and grade 3 adult-type diffuse gliomas: retrospective analysis of 112 cases
- Open Access
- 23 January 2025
- Published by Elsevier in Brain and Spine
- Vol. 5, 104193
Post-craniotomy infections: A point-by-point approach
- 23 January 2025
- Published by Elsevier in Brain and Spine
- Vol. 5, 104193
Open AccessPost-craniotomy infections: A point-by-point approach